<DOC>
	<DOCNO>NCT02666391</DOCNO>
	<brief_summary>The purpose present study evaluate safety exploratory efficacy umbilical cord mesenchymal stem cell patient ischemic heart disease .</brief_summary>
	<brief_title>Safety Exploratory Efficacy Study UCMSCs Patients With Ischemic Heart Disease ( SEESUPIHD )</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<criteria>Clinical diagnosis Ischemic cardiomyopathy cause acute occlusion severe stenosis anterior descend artery ; LVEF ( leave ventricular ejection fraction ) : 2545 % ; Age 18 70 , borh gender ; Women childbearing age agree take contraceptive measure whole study period ; No psychiatric illness speak dysfunction ; Informed consent . Structural heart disease , Valvular heart disease , Refractory hypertension ( Unstable blood pressure control ) , LVEF &lt; 24 % ; Serious primary disease liver , kidney hematopoietic system , Abnormal liver function ( glutamicpyruvic transaminase ( ALT ) , glutamicoxaloacetic transaminase ( AST ) 2 time higher normal value ) , creatinine ( Cr ) high upper limit normal value ; Patients suffer severe arrhythmia ; Patients suffer stent thrombosis ; Patients receive immunosuppressive therapy ; Patients tumor lethal disease ( expectation life &lt; 6 month ) ; Women plan pregnant pregnant nursing ; Allergic constitution ( Allergic two kind drug , food , pollen ) ; Other clinical trial participant within 3 month ; Investigators judge condition suitable inclusion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>